Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.-Reference-Cited by-同舟云学术

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

Published:2009-10 Issue: Volume:117 Page:S26-S43
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Lam Raymond W.,Kennedy Sidney H.,Grigoriadis Sophie,McIntyre Roger S.,Milev Roumen,Ramasubbu Rajamannar,Parikh Sagar V.,Patten Scott B.,Ravindran Arun V.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference147 articles.

1. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies;Addis;Psychol. Med.,2000

2. Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression;Alexopoulos;Am. J. Geriatr. Psychiatry,2008

3. Meta-analytical studies on new antidepressants;Anderson;Br. Med. Bull.,2001

4. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines;Anderson;J. Psychopharmacol.,2008

5. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn;Andrade;Pharmacoepidemiol. Drug Saf.,2009

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Major Depressive Disorder: Basic Principles;Clinical Textbook of Mood Disorders;2024-05-30

2. Antidepressant nonadherence and sexual dysfunction among young adult males: the cross-sectional YAMAN study;World Journal of Urology;2024-05-06

3. L’intérêt d’un modèle d’étude du rapport coût-efficacité des interventions pour traiter le trouble dépressif majeur au Canada;Canadian Medical Association Journal;2024-02-04

4. Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms;BMC Medicine;2024-01-25

5. Genome-wide transcriptomic and biochemical profiling of major depressive disorder: Unravelling association with susceptibility, severity, and antidepressant response;Genomics;2024-01